| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |